Xinhua News Agency, Changchun, March 19. Jilin City held a press conference on the prevention and control of the new crown pneumonia epidemic on the 19th to report that the direct cause of the deaths of the two new coronary pneumonia patients was not infected with the new coronavirus. Virus.
Liu Wenge, head of the Jilin City New Coronary Virus Pneumonia Medical Treatment Expert Team, Director of the Intensive Medicine Department of Jilin Central Hospital, and Chief Physician Liu Wenge said that two patients with new coronary pneumonia in Jilin City unfortunately passed away during the treatment process. , The local area has further clarified the cause of death by organizing the discussion of death cases. After discussion by the national, provincial and municipal expert groups, it is believed that the direct cause of the death of the two infected persons was not infection with the new coronavirus.
Death case 1, male, 65 years old, complicated with chronic renal failure-uremia, nephrotic syndrome, renal amyloidosis, coronary atherosclerotic heart disease and other basic diseases. Dialysis treatment will start in 2021. On March 9, 2022, due to syncope, he went to Jilin Chia Tai International Hospital for treatment and was admitted to the isolation ward. Later, due to the positive nucleic acid test for new coronary pneumonia, he was transferred to the Affiliated Hospital of Jilin Medical College for treatment. After admission, the patients were given primary care, oxygen inhalation, multifunctional ECG monitoring, Lianhua Qingwen granules, potassium-lowering resin, amoxicillin for anti-infection, antipyretic, coronary expansion, pain relief and other symptomatic treatments. During the treatment in the hospital, the patient suddenly appeared unresponsive without any incentive, breathing deeply, and the rescue was invalid, and he died clinically. Causes of death: hyperkalemia, severe metabolic acidosis, hypoglycemia, acute non-ST-segment elevation myocardial infarction.
Death case 2, male, 87 years old. After falling on March 11, 2022, he developed weakness in both lower limbs and slurred speech. He went to the local hospital for treatment. Later, due to a positive nucleic acid test, he was transferred to Jilin Central Hospital for treatment. The patient suffered from underlying diseases such as cerebral infarction, hypertension, and lumbar trauma. After admission, first-level nursing care was given, multi-functional monitoring, nasal cannula oxygen inhalation, oral administration of Lianhua Qingwen capsules, atomization inhalation and appropriate rehydration, as well as anti-inflammatory, expectorant, urinary catheterization and other treatments. During the treatment in the hospital, the patient suffered sudden dyspnea and cardiac arrest, and the rescue failed and died. Cause of death: acute massive pulmonary embolism. (End)